LAUNXP Biomedical , Ltd Net Tangible Assets

LAUNXP Biomedical , Ltd (6876.TWO) currently reports a net tangible assets of $370M as of June 2026. That compares with $290M in the prior-year period — up 29.3% year over year. Use the charts on this page to explore LAUNXP Biomedical , Ltd's net tangible assets history and peer comparisons.

LAUNXP Biomedical , Ltd's net tangible assets increased from $290M to $370M — a 29.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LAUNXP Biomedical , Ltd reported $370M in net tangible assets as of June 2026. That compares with $290M in the prior-year period — up 29.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $370M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LAUNXP Biomedical , Ltd, and consider following 6876.TWO for alerts when major investors trade the stock.

LAUNXP Biomedical , Ltd is classified in the Healthcare sector. On net tangible assets, it currently shows $370M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6876.TWO with unrelated industries.